Stockreport

Zymeworks Advances Clinical Candidate Incorporating Technology from Kairos Acquisition

Zymeworks Inc.  (ZYME) 
Last zymeworks inc. earnings: 3/2 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.zymeworks.com/overview
PDF Multifunctional Bispecific Antibody-Drug Conjugate;Data Scheduled for Presentation at AACR VANCOUVER, British Columbia--(BUSINESS WIRE)-- [Read more]